Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole System

NCT ID: NCT06705673

Last Updated: 2024-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-02

Study Completion Date

2025-02-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In pediatric rheumatic diseases, joint swelling, effusion, tenderness, and painful restriction of joint movement, particularly in weight-bearing joints, frequently alter walking function. These changes affect temporal and spatial parameters of gait, as well as kinematic and kinetic characteristics, leading to functional limitations. Comprehensive physical assessments in patients may not always predict changes in gait parameters. Therefore, incorporating objective methods related to gait and balance into physical evaluations is essential for functional insights and clinical decision-making, aiming to prevent adaptive mechanisms that could negatively affect gait function in the long term. In this context, smart insoles have emerged as a new tool for gait analysis, offering an alternative to high-cost, lab-based equipment. The Digitsole Pro® system can measure gait profile and variables in real-life conditions. A review of the literature reveals no studies utilizing smart insole-based gait assessments in pediatric rheumatic patients. The aim of our study is to investigate the gait profile and variables of children and adolescents with pediatric rheumatic disease using the next-generation Digitsole Pro® smart insole system, and to compare the results with those of healthy peers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Juvenile Idiopathic Arthritis (JIA) Familial Mediterranean Fever (FMF ) Healthy Controls

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Juvenile Idiopathic Arthritis

Patients diagnosed with JIA who are being followed at the Istanbul Medical Faculty Pediatric Rheumatology Clinic will be included in the study.

No interventions assigned to this group

Familial Mediterranean Fever

Patients diagnosed with FMF who are being followed at the Istanbul Medical Faculty Pediatric Rheumatology Clinic will be included in the study.

No interventions assigned to this group

Healthy control

For the healthy control group, healthy children and adolescents without any illnesses who volunteer to participate in the study will be included.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children and adolescents with pediatric rheumatic disease:

* Aged 6-18 years
* Diagnosed with JIA or FMF at least 6 months ago at the Istanbul Medical Faculty Pediatric Rheumatology Clinic

Healthy children and adolescents:

* Aged 6-18 years
* Willing to participate in the study

Exclusion Criteria

* History of trauma or surgery affecting the musculoskeletal system in the last 6 months
* Presence of a chronic disease other than JIA or FMF
* Acute pain for any reason
* Visual or hearing problems
* Cognitive impairment that prevents understanding of given instructions


* History of trauma or surgery affecting the musculoskeletal system in the last 6 months
* Hearing or visual problems
* Acute pain for any reason
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asya Albayrak

MSc

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nilay Arman, PhD

Role: PRINCIPAL_INVESTIGATOR

Istanbul University - Cerrahpasa

Asena Yekdaneh, MSc

Role: PRINCIPAL_INVESTIGATOR

Fenerbahce University

Asya Albayrak, MSc

Role: PRINCIPAL_INVESTIGATOR

Istanbul University - Cerrahpasa

Fatma Gul Demirkan, Dr

Role: PRINCIPAL_INVESTIGATOR

Kanuni Sultan Suleyman Eğitim ve Araştırma Hastanesi

Nuray Aktay Ayaz, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Istanbul University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nilay Arman, PhD

Role: CONTACT

+905534558707

Asena Yekdaneh, MSc

Role: CONTACT

+905386594786

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

digitsole

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.